Starting tonight at 10:30 p.m. until Sunday at 8 a.m. we will be off the air for important maintenance. GPB Passport and GPB on YouTube and Hulu will still be available. We apologize for any inconvenience.
A new study shows that as people mostly remained indoors during lockdowns last year, many bird species found less noisy and polluted cities more inviting.
President Biden has ordered more than 17 million health care workers to get a COVID-19 vaccine. Some health care employers fear losing large numbers of workers who don't want the shots.
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
Dr. Janet Woodcock, an administrative veteran of the Food and Drug Administration since the 1980s, has been acting director of the agency since January. Why is the permanent job so hard to fill?
Some producers can't source glass bottles, the cost to import liquor has gone up, and there is a shortage of truck drivers. Also, it just takes a long time to make some types of booze.
Though infections are still sky-high, the U.S. may be turning a corner, according to a consortium of researchers who forecast the pandemic. And we may well be spared a winter surge.
U.S. Education Secretary Miguel Cardona is hopping a purple bus for his "Return-to-School Road Trip." His message to students and educators: It's good to be back.
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
Pfizer and BioNTech say that early trial results show their vaccine established a strong antibody response against the coronavirus. FDA review is still needed.
About a quarter of U.S. health care workers have refused the COVID-19 vaccine as of July. They share demographic traits with other unvaccinated people and are putting hospitals in a tough spot.
Advisers to the Food and Drug Administration supported boosters of the Pfizer-BioNTech COVID-19 vaccine for a smaller group of people after they voted against recommending it for anyone 16 and older.
But the researchers stressed that all three vaccines, including the Pfizer and Johnson & Johnson shots, provide strong protection against people getting so sick that they end up in the hospital.